Literature DB >> 18582432

Impact of short- and medium-chain organic acids, acylcarnitines, and acyl-CoAs on mitochondrial energy metabolism.

Sven Wolfgang Sauer1, Juergen G Okun, Georg F Hoffmann, Stefan Koelker, Marina A Morath.   

Abstract

Accumulation of organic acids as well as their CoA and carnitine esters in tissues and body fluids is a common finding in organic acidurias, beta-oxidation defects, Reye syndrome, and Jamaican vomiting sickness. Pathomechanistic approaches for these disorders have been often focused on the effect of accumulating organic acids on mitochondrial energy metabolism, whereas little is known about the pathophysiologic role of short- and medium-chain acyl-CoAs and acylcarnitines. Therefore, we investigated the impact of short- and medium-chain organic acids, acylcarnitines, and acyl-CoAs on central components of mitochondrial energy metabolism, namely alpha-ketoglutarate dehydrogenase complex, pyruvate dehydrogenase complex, and single enzyme complexes I-V of respiratory chain. Although at varying degree, all acyl-CoAs had an inhibitory effect on pyruvate dehydrogenase complex and alpha-ketoglutarate dehydrogenase complex activity. Effect sizes were critically dependent on chain length and number of functional groups. Unexpectedly, octanoyl-CoA was shown to inhibit complex III. The inhibition was noncompetitive regarding reduced ubiquinone and uncompetitive regarding cytochrome c. In addition, octanoyl-CoA caused a blue shift in the gamma band of the absorption spectrum of reduced complex III. This effect may play a role in the pathogenesis of medium-chain and multiple acyl-CoA dehydrogenase deficiency, Reye syndrome, and Jamaican vomiting sickness which are inherited and acquired conditions of intracellular accumulation of octanoyl-CoA.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18582432     DOI: 10.1016/j.bbabio.2008.05.447

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  25 in total

Review 1.  Mitochondrial energy metabolism in neurodegeneration associated with methylmalonic acidemia.

Authors:  Daniela R Melo; Alicia J Kowaltowski; Moacir Wajner; Roger F Castilho
Journal:  J Bioenerg Biomembr       Date:  2011-02       Impact factor: 2.945

2.  Inhibition of β-oxidation is not a valid therapeutic tool for reducing oxidative stress in conditions of neurodegeneration.

Authors:  Peter Schönfeld; Georg Reiser
Journal:  J Cereb Blood Flow Metab       Date:  2016-07-20       Impact factor: 6.200

Review 3.  Current concepts in organic acidurias: understanding intra- and extracerebral disease manifestation.

Authors:  Stefan Kölker; Peter Burgard; Sven W Sauer; Jürgen G Okun
Journal:  J Inherit Metab Dis       Date:  2013-03-20       Impact factor: 4.982

Review 4.  Metabolic disturbances in diseases with neurological involvement.

Authors:  João M N Duarte; Patrícia F Schuck; Gary L Wenk; Gustavo C Ferreira
Journal:  Aging Dis       Date:  2013-11-30       Impact factor: 6.745

5.  Metabolic decompensation in methylmalonic aciduria: which biochemical parameters are discriminative?

Authors:  Tamaris Zwickler; Gisela Haege; Alina Riderer; Friederike Hörster; Georg F Hoffmann; Peter Burgard; Stefan Kölker
Journal:  J Inherit Metab Dis       Date:  2012-01-17       Impact factor: 4.982

Review 6.  Inhibitors of succinate: quinone reductase/Complex II regulate production of mitochondrial reactive oxygen species and protect normal cells from ischemic damage but induce specific cancer cell death.

Authors:  Stephen J Ralph; Rafael Moreno-Sánchez; Jiri Neuzil; Sara Rodríguez-Enríquez
Journal:  Pharm Res       Date:  2011-08-24       Impact factor: 4.200

Review 7.  Short- and medium-chain fatty acids in energy metabolism: the cellular perspective.

Authors:  Peter Schönfeld; Lech Wojtczak
Journal:  J Lipid Res       Date:  2016-04-14       Impact factor: 5.922

8.  Usefulness of biochemical parameters in decision-making on the start of emergency treatment in patients with propionic acidemia.

Authors:  Tamaris Zwickler; Alina Riderer; Gisela Haege; Georg F Hoffmann; Stefan Kölker; Peter Burgard
Journal:  J Inherit Metab Dis       Date:  2013-06-25       Impact factor: 4.982

Review 9.  Short-chain acyl-CoA dehydrogenase deficiency: from gene to cell pathology and possible disease mechanisms.

Authors:  Zahra Nochi; Rikke Katrine Jentoft Olsen; Niels Gregersen
Journal:  J Inherit Metab Dis       Date:  2017-05-17       Impact factor: 4.982

10.  Acyl-CoA thioesterase 9 (ACOT9) in mouse may provide a novel link between fatty acid and amino acid metabolism in mitochondria.

Authors:  Veronika Tillander; Elisabet Arvidsson Nordström; Jenny Reilly; Malgorzata Strozyk; Paul P Van Veldhoven; Mary C Hunt; Stefan E H Alexson
Journal:  Cell Mol Life Sci       Date:  2013-07-18       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.